maprotiline has been researched along with Depression, Endogenous in 250 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A group of 25 patients treated with maprotiline was studied to test the question of second-generation antidepressant effectiveness in chronic pain." | 9.05 | Maprotiline in pain-depression. ( Lindsay, PG; Olsen, RB, 1985) |
| " We investigated the relation of maprotiline induced weight gain to serum ghrelin and adiponectin levels, as well as insulin resistance in lean subjects with depressive disorder." | 7.74 | Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity. ( Acikel, C; Bolu, E; Doruk, A; Erdil, A; Gulsun, M; Pinar, M; Tasci, I, 2008) |
| "Eleven McLean Hospital (Belmont, Mass) depressed patients who experienced seizures while receiving maprotiline hydrochloride are presented, as are data on 87 cases reported to the manufacturer (Ciba-Geigy)." | 7.67 | Maprotiline treatment in depression. A perspective on seizures. ( Cole, JO; Dessain, EC; Schatzberg, AF; Woods, BT, 1986) |
| "Atrial flutter developed in an 80-year-old woman after 10 days of treatment with maprotiline at therapeutic concentrations." | 7.67 | Atrial flutter and maprotiline: case report. ( Herzog, C; Lesar, T; Tollefson, G, 1984) |
| "Maprotiline was administered in doses up to 150 mg/day during the first 2 weeks after which time the dose could be increased incrementally up to 300 mg/day if indicated clinically." | 6.65 | Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. ( Cole, JO; Kruger, ER; Maruta, T; Orsulak, PJ; Rohde, WA; Rosenbaum, AH; Schatzberg, AF; Schildkraut, JJ, 1981) |
| "Seventy-five outpatients with major depressive disorder (RDC) were randomly referred to treatment with a dominant serotonin (5-HT) reuptake blocker (zimeldine, 100 mg, b." | 5.06 | Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study. ( Hällström, T; Nyström, C, 1987) |
| "Using a simple S1S2-R paradigm, acoustically evoked potentials, CNV, and PINV were recorded in 59 patients with major depressive disorder before and during a 4 week double blind pharmacological treatment with either amitriptyline (AT) or oxaprotiline (OT)." | 5.06 | [Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline]. ( Giedke, H; Heimann, H; Rein, W, 1987) |
| "Seventy-five outpatients with major depressive disorder (RDC) were randomly referred to treatment with a dominant 5-HT reuptake blocker (zimeldine, 100 mg b." | 5.06 | Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects. ( Hällström, T; Kelder, D; Nyström, C; Ross, SB, 1986) |
| "A group of 25 patients treated with maprotiline was studied to test the question of second-generation antidepressant effectiveness in chronic pain." | 5.05 | Maprotiline in pain-depression. ( Lindsay, PG; Olsen, RB, 1985) |
| "Maprotiline hydrochloride tablets were given to 266 patients with either a dysthymic disorder or a major depressive disorder." | 5.05 | Multicenter evaluation of maprotiline hydrochloride for treatment of depression. ( , 1984) |
| "Seventy-five outpatients with major depressive disorder (RDC) were randomly referred to treatment with a dominant serotonin (5-HT) uptake inhibiting drug (zimeldine, 100 mg b." | 5.05 | Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects. ( Hällström, T; Nyström, C, 1985) |
| " We investigated the relation of maprotiline induced weight gain to serum ghrelin and adiponectin levels, as well as insulin resistance in lean subjects with depressive disorder." | 3.74 | Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity. ( Acikel, C; Bolu, E; Doruk, A; Erdil, A; Gulsun, M; Pinar, M; Tasci, I, 2008) |
| " However, our patient with recidivation of unipolar depressive disorder developed severe laboratory abnormalities and clinical symptoms during therapy with maprotiline (Ludiomil) and opipramol (Insidon)." | 3.70 | Hepatitis caused by antidepressive therapy with maprotiline and opipramol. ( Berger, M; Braun, JS; Geiger, R; Schäffer, S; Wehner, H, 1998) |
| " the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder." | 3.68 | Alpha 2-adrenoceptor responsivity in depression: effect of chronic treatment with moclobemide, a selective MAO-A-inhibitor, versus maprotiline. ( Laux, G; Lesch, KP; Mueller, T, 1990) |
| "Atrial flutter developed in an 80-year-old woman after 10 days of treatment with maprotiline at therapeutic concentrations." | 3.67 | Atrial flutter and maprotiline: case report. ( Herzog, C; Lesar, T; Tollefson, G, 1984) |
| "Eleven McLean Hospital (Belmont, Mass) depressed patients who experienced seizures while receiving maprotiline hydrochloride are presented, as are data on 87 cases reported to the manufacturer (Ciba-Geigy)." | 3.67 | Maprotiline treatment in depression. A perspective on seizures. ( Cole, JO; Dessain, EC; Schatzberg, AF; Woods, BT, 1986) |
| "The citalopram-treated patients in whom AAM developed were significantly older than those in whom it did not (about 10 years, P < 0." | 2.69 | Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients? ( Barak, Y; Kimhi, R; Weizman, R, 2000) |
| " Patients with inadequate treatment response (paroxetine group, n = 86; maprotiline group, n = 88) were again randomized to either continuation of the previous dosage (paroxetine, n = 36; maprotiline, n = 48) or increased doses, i." | 2.68 | Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response. ( Benkert, O; Meister, W; Philipp, M; Staab, HJ; Szegedi, A; Wetzel, H, 1997) |
| " Its plasma levels (40 ng/ml) were one third to one half of the values obtained with maprotiline in the same daily dosage (150 mg)." | 2.67 | [Results of a clinical trial of levoprotiline]. ( Bornová, L; David, I; Filip, V; Höschl, C; Karen, P; Seifertová, D, 1992) |
| " Although there was a fixed-flexible dosage design it was apparent that 16 patients (89%) of the fluvoxamine group and all patients of the maprotiline group received a dosage between 200 and 300 mg/day in the last week of the trial." | 2.67 | Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects. ( Dötsch, M; Kasper, S; Kick, H; Möller, HJ; Vieira, A, 1993) |
| "Moclobemide was the better-tolerated drug, producing fewer side effects than maprotiline did: in particular, fewer instances of somnolence and dry mouth." | 2.67 | Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners. ( Dick, P; Gachoud, JP; Köhler, M, 1994) |
| "Fluvoxamine was found to be a potent anti-panic agent." | 2.66 | Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. ( Den Boer, JA; Westenberg, HG, 1988) |
| " The study was conducted over a period of 28 days and the dosage of each substance, after being gradually increased, was stabilized at 150 mg." | 2.66 | CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study. ( Binz, U; Hole, G; Steiner, B; Wendt, G; Wolfersdorf, M, 1988) |
| "In a double-blind study on 38 unselected depressive inpatients (19 per group) suffering from endogenous and psychogenic depression, oxaprotiline, a new tetracyclic compound, a hydroxylized maprotiline with a highly selective norepinephrine reuptake inhibition, was compared with clomipramine over a period of 28 days in a daily dosage of 150 mg." | 2.66 | Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients. ( Binz, U; Hole, G; Metzger, R; Wendt, G; Wolfersdorf, M, 1987) |
| "A negative response to sleep deprivation, an increase in MAO activity as a result of sleep deprivation, the appearance of signs of fatigue (vigilance index) in the EEG after the first infusion as well as obvious autonomic symptoms before the start of treatment are indicative of a response to maprotiline." | 2.66 | Biological predictors of success of antidepressant drug therapy. ( Fähndrich, E, 1987) |
| " Oxaprotiline was given in a dosage up to 225 mg over a period of 28 days." | 2.66 | Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial. ( Blaschke, D; Dieterle, D; Laakmann, G; Schmauss, M, 1985) |
| " For the first week of the trial, 32 patients received 30 mg/day of mianserin and 30 patients received 75 mg/day of maprotiline; for the next three weeks, the dosage of each drug was doubled." | 2.66 | A double-blind trial comparing mianserin and maprotiline in depressed inpatients. ( Abreu-Lima, C; Fernandes, R; Ferreira, L; Palha, AP; Ramalhão, C, 1985) |
| "Maprotiline was associated with decreased PVCs in patients with a "high" baseline rate, while doxepin was associated with increased PVCs in this group." | 2.65 | Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients. ( Ahles, S; Gwirtsman, H; Halaris, A; Hill, MA; Schwarcz, G; Shah, P, 1984) |
| " A significant positive correlation was obtained between dosage and blood levels of maprotiline and doxepin, but there was no correlation between blood levels and clinical response." | 2.65 | Therapeutic superiority of maprotiline versus doxepin in geriatric depression. ( Ahles, S; DeMet, E; Gwirtsman, HE; Halaris, A; Hill, MA, 1983) |
| "Outpatients with endogenous depression diagnosed according to the research diagnostic criteria of Feighner et al." | 2.65 | Zimelidine vs maprotiline in depressed outpatients. A preliminary report. ( d'Elia, G; Hällström, T; Nyström, C; Ottosson, JO, 1981) |
| " In most cases, the starting dosage was 75 mg/day with a mean of 71." | 2.65 | Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability. ( , 1983) |
| "50 patients suffering from endogenous depression were admitted to a double-blind study comparing the efficacy of nomifensine and maprotiline and the side effects associated with treatment." | 2.65 | Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects. ( Levin, A, 1982) |
| " 20 patients of the control group were treated during this period with maprotiline of the same dosage but did not received EMD 21 657 as co-medication." | 2.65 | Neurotropic drugs as co-medication to psychotropics. Combined administration of a neurotropic drug and a tetracyclic antidepressant. ( Pöldinger, W; Reinhardt, B, 1980) |
| "The presence or absence of cardiac arrhythmias was recorded." | 2.65 | Mianserin, maprotiline and intracardiac conduction. ( Edwards, JG; Goldie, A, 1983) |
| "Maprotiline was administered in doses up to 150 mg/day during the first 2 weeks after which time the dose could be increased incrementally up to 300 mg/day if indicated clinically." | 2.65 | Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. ( Cole, JO; Kruger, ER; Maruta, T; Orsulak, PJ; Rohde, WA; Rosenbaum, AH; Schatzberg, AF; Schildkraut, JJ, 1981) |
| "Severe orthostatic hypotension is more likely to develop in depressed patients with left ventricular impairment and/or in patients taking other drugs like diuretics or vasodilators." | 2.38 | Review of the cardiovascular effects of heterocyclic antidepressants. ( Glassman, AH; Preud'homme, XA, 1993) |
| "Fluoxetine was characterised by predominance of a stimulating effect from the first days of treatment as well as by relatively late manifestation of very thymoleptic and tranquilizing impact (during 3-4 weeks)." | 1.30 | [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine]. ( Lopukhov, IG, 1997) |
| "Because of a depressive syndrome, a 39-year-old patient received 20 mg fluoxetine per day." | 1.29 | [A case of rare side effects of certain antidepressive drugs]. ( Haenel, T; Stöckli, HR; Truog, P, 1995) |
| " In modest dosages, maprotiline seems relatively safe in depressed cardiac patients." | 1.28 | Safety of maprotiline in treatment of cardiac patients with left anterior hemiblock. ( Ananth, J; Ghadirian, AM, 1989) |
| "3H-Imipramine binding was measured in freshly prepared platelet membranes from 47 drug-free major depressives and 46 healthy controls." | 1.28 | 3H-imipramine binding to freshly prepared platelet membranes in depression. ( Davies, SL; Hale, AS; Horton, RW; Katona, CL; Kelly, JS; Kerry, SM; Paykel, ES; Theodorou, AE, 1989) |
| " The authors suggest that Ludiomil at a maximal dosage of 150 mg/d can be considered a relatively safe and effective antidepressant." | 1.28 | Maprotiline (Ludiomil) treatment of mental depression--a clinical report of 65 cases. ( Li, SW; Yan, HQ, 1989) |
| "The reaction to sleep deprivation (SD) and the changes in MAO activity resulting from sleep deprivation were tested on 60 depressive patients as predictors for antidepressant drug treatment." | 1.27 | [When do I give which antidepressant in the individual case?]. ( Fähndrich, E, 1984) |
| " Chronic administration of imipramine-HCl (1 and 5 mg/kg, i." | 1.27 | Effects of antidepressant drugs on a quickly-learned conditioned-suppression response in mice. ( Kameyama, T; Nagasaka, M; Yamada, K, 1985) |
| "In the neurotic depression group 23 patients were subclassified as Primary Minor Depression, and 52% of them showed non-suppressor response to DST." | 1.27 | Dexamethasone suppression test as a predictor of drug treatment response. ( Arató, M; Grof, P; Rihmer, Z; Szádóczky, E, 1984) |
| "Maprotiline was effective as an antidepressant in some patients." | 1.27 | Maprotiline in affective illness. Plasma concentration and clinical response. ( Burrows, GD; Maguire, KP; McIntyre, IM; Norman, TR; Scoggins, BA, 1983) |
| "Maprotiline is a tetracyclic antidepressant which appears to have accounted for a relatively large proportion of the seizures associated with antidepressant use." | 1.27 | Seizures associated with high maprotiline serum concentrations. ( Molnar, G, 1983) |
| "Myoclonus is a movement disorder of various etiologies." | 1.27 | Antidepressants and myoclonus: case report. ( DeCastro, RM, 1985) |
| "Maprotiline has been reported to be less likely to cause epileptic seizures than the tricyclic antidepressants." | 1.26 | Maprotiline and seizures. ( Hoffman, BF; Wachsmuth, R, 1982) |
| "After four weeks 66% of the endogenous depressions and 53% of the exhaustion depressions had completely regressed." | 1.26 | [Management of treatment-resistant depression without ECT (author's transl)]. ( Adams, C; Gastpar, M; Kielholz, P; Terzani, S, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 176 (70.40) | 18.7374 |
| 1990's | 62 (24.80) | 18.2507 |
| 2000's | 11 (4.40) | 29.6817 |
| 2010's | 1 (0.40) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshino, T | 1 |
| Nisijima, K | 1 |
| Shioda, K | 1 |
| Kato, S | 1 |
| Yamada, J | 1 |
| Sugimoto, Y | 1 |
| Shen, ZM | 1 |
| Zhu, ML | 1 |
| Zhao, AQ | 1 |
| Bertolín-Guillén, JM | 1 |
| Climent-Díaz, B | 1 |
| Navarré-Gimeno, A | 1 |
| Luo, HC | 1 |
| Qian, RQ | 1 |
| Zhao, XY | 1 |
| Bi, J | 1 |
| Xin, H | 1 |
| Jiang, X | 1 |
| Xu, K | 1 |
| Yan, S | 1 |
| Pinar, M | 1 |
| Gulsun, M | 1 |
| Tasci, I | 1 |
| Erdil, A | 1 |
| Bolu, E | 1 |
| Acikel, C | 1 |
| Doruk, A | 1 |
| Kielholz, P | 4 |
| Terzani, S | 2 |
| Gastpar, M | 4 |
| Adams, C | 2 |
| Zapletálek, M | 5 |
| Zbytovský, J | 2 |
| Libiger, J | 3 |
| Pazdírek, S | 2 |
| Cápová, E | 1 |
| Pöldinger, W | 3 |
| Alac, S | 1 |
| Krebs-Roubicek, E | 1 |
| Veith, RC | 1 |
| Burchinskiĭ, SG | 1 |
| Arató, M | 2 |
| Rihmer, Z | 2 |
| Szádóczky, E | 1 |
| Grof, P | 1 |
| Mück-Seler, D | 2 |
| Deanović, Z | 2 |
| Jamnicky, B | 1 |
| Jakupcević, M | 1 |
| Mihovilović, M | 1 |
| Ahles, S | 2 |
| Gwirtsman, H | 1 |
| Halaris, A | 2 |
| Shah, P | 1 |
| Schwarcz, G | 1 |
| Hill, MA | 2 |
| Norman, TR | 1 |
| Burrows, GD | 1 |
| Maguire, KP | 1 |
| McIntyre, IM | 1 |
| Scoggins, BA | 1 |
| Edwards, JG | 3 |
| Goldie, A | 3 |
| Dominguez, RA | 1 |
| Pethö, B | 1 |
| Karczag, I | 1 |
| Gwirtsman, HE | 1 |
| DeMet, E | 1 |
| Lydiard, RB | 1 |
| Pottash, AL | 1 |
| Gold, MS | 1 |
| Molnar, G | 1 |
| Seeler, W | 1 |
| Wittgens, R | 1 |
| Parker, J | 1 |
| Lahmeyer, H | 1 |
| d'Elia, G | 1 |
| Hällström, T | 4 |
| Nyström, C | 4 |
| Ottosson, JO | 1 |
| Claghorn, JL | 1 |
| Mathew, RJ | 1 |
| Náhunek, K | 4 |
| Svestka, J | 4 |
| Cesková, E | 3 |
| Rysánek, R | 3 |
| Atri, PB | 1 |
| Julius, DA | 1 |
| Fähndrich, E | 7 |
| Yufu, N | 1 |
| Itoh, M | 1 |
| Notomi, A | 1 |
| Nakao, H | 1 |
| Greden, JF | 1 |
| Price, HL | 1 |
| Genero, N | 1 |
| Feinberg, M | 1 |
| Levine, S | 1 |
| Léger, JM | 1 |
| Lombertie, E | 1 |
| Malauzat, D | 1 |
| Volpi, F | 1 |
| Perez, OE | 1 |
| Henriquez, N | 1 |
| Tollefson, G | 2 |
| Lesar, T | 2 |
| Herzog, C | 1 |
| Kabes, J | 3 |
| Dostal, T | 3 |
| Balon, R | 2 |
| Papezová, H | 1 |
| Moldawsky, RJ | 1 |
| Gaertner, HJ | 2 |
| Giedke, H | 4 |
| Breyer-Pfaff, U | 3 |
| Indaco, A | 1 |
| Orefice, G | 1 |
| Carrieri, P | 1 |
| Levin, A | 1 |
| Binz, U | 4 |
| Wendt, G | 5 |
| Schatzberg, AF | 4 |
| Rosenbaum, AH | 3 |
| Orsulak, PJ | 3 |
| Rohde, WA | 1 |
| Maruta, T | 2 |
| Kruger, ER | 1 |
| Cole, JO | 4 |
| Schildkraut, JJ | 3 |
| Schwartz, L | 1 |
| Swaminathan, S | 1 |
| Hoffman, BF | 1 |
| Wachsmuth, R | 1 |
| Holliday, W | 1 |
| Brasfield, KH | 1 |
| Powers, B | 1 |
| Finke, G | 1 |
| Wegener, G | 1 |
| Kim, WY | 1 |
| Zung, WW | 1 |
| Magill, M | 1 |
| Moore, JT | 1 |
| George, DT | 1 |
| Nemeroff, CB | 2 |
| Evans, DL | 2 |
| Albala, AA | 1 |
| Weinberg, N | 1 |
| Allen, SM | 1 |
| Ramirez, AL | 1 |
| Müller-Oerlinghausen, B | 1 |
| Kettl, P | 1 |
| DePaulo, JR | 1 |
| Watanabe, S | 1 |
| Yokoyama, S | 1 |
| Kubo, S | 1 |
| Iwai, H | 1 |
| Kuyama, C | 1 |
| van der Velde, CD | 1 |
| Logue, JN | 1 |
| Sachais, BA | 1 |
| Reinhardt, B | 1 |
| Montgomery, SA | 2 |
| McAuley, R | 1 |
| Montgomery, DB | 2 |
| Dawling, S | 1 |
| Braithwaite, RA | 1 |
| Sederberg-Olsen, P | 1 |
| Lauritsen, B | 1 |
| Husfeldt, P | 1 |
| Rønne, H | 1 |
| Ekstrøm, K | 1 |
| Bjørndal, F | 1 |
| Holst, B | 1 |
| Jakobsen, K | 1 |
| Shader, RI | 1 |
| Greenblatt, DJ | 1 |
| Tsaras, G | 1 |
| Ambrus, J | 1 |
| Grüter, W | 1 |
| Tesarová, O | 1 |
| Roth, Z | 1 |
| Rifkin, A | 1 |
| Minuti, E | 1 |
| Gallo, V | 1 |
| Rektor, L | 1 |
| Misaurec, J | 1 |
| Horká, E | 1 |
| Cerná, V | 1 |
| Hanus, H | 1 |
| Kindernayová, H | 1 |
| Valach, M | 1 |
| Vinar, O | 1 |
| Benesová, O | 1 |
| Vencovský, E | 2 |
| Kudrnová, K | 1 |
| Soucek, K | 1 |
| Faltus, F | 3 |
| Bick, P | 1 |
| Settle, EC | 1 |
| Edelbroek, PM | 1 |
| de Haas, EJ | 1 |
| de Wolff, FA | 1 |
| Cording-Tömmel, C | 1 |
| von Zerssen, D | 2 |
| Lerfald, SC | 1 |
| Golfinopoulos, G | 1 |
| Laakmann, G | 2 |
| Böning, J | 1 |
| Ehsanullah, RS | 1 |
| Grab, EL | 1 |
| Brogmus, KE | 1 |
| Lesch, A | 1 |
| Ulrich, G | 2 |
| Haug, HJ | 2 |
| König, F | 3 |
| Stumpp, W | 1 |
| Wolfersdorf, M | 6 |
| Leibfarth, M | 1 |
| Fuchs, G | 1 |
| Kaschka, WP | 1 |
| Haenel, T | 2 |
| Stöckli, HR | 1 |
| Truog, P | 1 |
| Lefebvre, H | 1 |
| Noblet, C | 1 |
| Moore, N | 1 |
| Wolf, LM | 1 |
| Sato, T | 2 |
| Sakado, K | 2 |
| Sato, S | 1 |
| Straub, R | 2 |
| Gachoud, JP | 1 |
| Dick, P | 1 |
| Köhler, M | 1 |
| Vaz-Serra, A | 1 |
| Figueira, ML | 1 |
| Firmino, H | 1 |
| Albuquerque, AJ | 1 |
| Jara, JM | 1 |
| Pestana, LC | 1 |
| Hoencamp, E | 3 |
| Haffmans, PM | 3 |
| Duivenvoorden, H | 1 |
| Knegtering, H | 1 |
| Dijken, WA | 5 |
| Hoogduin, CA | 1 |
| Nolen, WA | 4 |
| van Dyck, R | 1 |
| Steinmeyer, EM | 1 |
| Vorbach, EU | 1 |
| Arnoldt, KH | 1 |
| Filip, V | 4 |
| Höschl, C | 3 |
| Karen, P | 3 |
| Seifertová, D | 3 |
| Bornová, L | 2 |
| Prasková, H | 2 |
| Prasko, J | 1 |
| Bech, P | 1 |
| Andrade, C | 1 |
| David, I | 2 |
| Albrecht, V | 1 |
| Palus, M | 1 |
| Steiger, A | 1 |
| Gerken, A | 1 |
| Benkert, O | 4 |
| Holsboer, F | 1 |
| Stassen, HH | 1 |
| Delini-Stula, A | 2 |
| Angst, J | 2 |
| Fuchs, A | 1 |
| Hehnke, U | 1 |
| Erhart, C | 1 |
| Schell, C | 1 |
| Pramshohler, B | 1 |
| Danninger, B | 1 |
| Schautzer, F | 1 |
| Yazici, O | 1 |
| Aricioğlu, F | 1 |
| Gürvit, G | 1 |
| Uçok, A | 1 |
| Taştaban, Y | 1 |
| Canberk, O | 1 |
| Ozgüroğlu, M | 1 |
| Durat, T | 1 |
| Sahin, D | 1 |
| Glassman, AH | 1 |
| Preud'homme, XA | 1 |
| Katz, RJ | 2 |
| Lott, M | 1 |
| Landau, P | 1 |
| Waldmeier, P | 1 |
| Kasper, S | 4 |
| Dötsch, M | 1 |
| Kick, H | 3 |
| Vieira, A | 3 |
| Möller, HJ | 4 |
| Mikkelsen, H | 1 |
| Schnyder, U | 1 |
| Koller-Leiser, A | 1 |
| Hewer, W | 1 |
| Rost, W | 1 |
| Gattaz, WF | 1 |
| Parker, G | 1 |
| Suzuki, T | 2 |
| Kurita, H | 1 |
| Hori, T | 1 |
| Sasaki, M | 1 |
| Baba, A | 1 |
| Shiraishi, H | 1 |
| Piletz, JE | 1 |
| Ko, HC | 1 |
| Lu, RB | 1 |
| Shiah, IS | 1 |
| Hwang, CC | 1 |
| Szegedi, A | 3 |
| Wetzel, H | 3 |
| Staab, HJ | 1 |
| Meister, W | 1 |
| Philipp, M | 3 |
| Angersbach, D | 2 |
| Dunbar, GC | 1 |
| Schwarze, H | 1 |
| Lopukhov, IG | 1 |
| Löble, M | 1 |
| Wössner, S | 1 |
| Hauger, B | 1 |
| Vormfelde, SV | 1 |
| Bitsch, A | 1 |
| Meineke, I | 1 |
| Gundert-Remy, UM | 1 |
| Gleiter, CH | 1 |
| Braun, JS | 1 |
| Geiger, R | 1 |
| Wehner, H | 1 |
| Schäffer, S | 1 |
| Berger, M | 2 |
| Isotani, H | 1 |
| Kameoka, K | 1 |
| Pisani, F | 1 |
| Spina, E | 1 |
| Oteri, G | 1 |
| Hirano, S | 1 |
| Narita, T | 1 |
| Kusunoki, K | 1 |
| Kato, J | 1 |
| Goto, M | 1 |
| Uehara, T | 1 |
| Leroi, AM | 1 |
| Lalaude, O | 1 |
| Antonietti, M | 1 |
| Touchais, JY | 1 |
| Ducrotte, P | 1 |
| Menard, JF | 1 |
| Denis, P | 1 |
| Barak, Y | 1 |
| Kimhi, R | 1 |
| Weizman, R | 1 |
| Martényi, F | 1 |
| Dossenbach, M | 1 |
| Mraz, K | 1 |
| Metcalfe, S | 1 |
| Peschina, W | 1 |
| Conca, A | 1 |
| König, P | 1 |
| Fritzsche, H | 1 |
| Beraus, W | 1 |
| Hocqueloux, L | 1 |
| Gallien, S | 1 |
| Bornstain, C | 1 |
| Molina, JM | 1 |
| Normann, C | 1 |
| Lieb, K | 1 |
| Walden, J | 1 |
| Noguchi, S | 1 |
| Fukuda, Y | 1 |
| Inukai, T | 1 |
| Winter, R | 1 |
| Vetter, P | 1 |
| Voll, G | 3 |
| Höflich, G | 1 |
| Danos, P | 1 |
| Schmidt, R | 1 |
| Kontsevoĭ, VA | 1 |
| Kolibash, E | 1 |
| Piatnitskiĭ, AN | 1 |
| Korzhinkova, V | 1 |
| Andrusenko, MP | 1 |
| Kostrikina, IE | 1 |
| Steiner, B | 2 |
| Keller, F | 1 |
| Hole, G | 3 |
| Lei, M | 1 |
| Jakovljević, M | 1 |
| Riehl, T | 1 |
| Dietzfelbinger, T | 1 |
| Wernicke, T | 1 |
| de Jonghe, F | 1 |
| Ravelli, DP | 1 |
| Tuynman-Qua, H | 1 |
| Rouillon, F | 1 |
| Serrurier, D | 1 |
| Miller, HD | 1 |
| Gerard, MJ | 1 |
| Lesch, KP | 1 |
| Laux, G | 4 |
| Mueller, T | 1 |
| Classen, W | 3 |
| Vanelle, JM | 3 |
| Poirier, MF | 4 |
| Benkelfat, C | 4 |
| Galinowski, A | 1 |
| Sechter, D | 2 |
| Suzini de Luca, H | 1 |
| Lôo, H | 4 |
| Schifano, F | 1 |
| Garbin, A | 1 |
| Renesto, V | 1 |
| De Dominicis, MG | 1 |
| Trinciarelli, G | 1 |
| Silvestri, A | 1 |
| Magni, G | 1 |
| De Vanna, M | 1 |
| Kummer, J | 1 |
| Agnoli, A | 1 |
| Gentili, P | 1 |
| Lorizio, A | 1 |
| Anand, R | 1 |
| D'haenen, H | 1 |
| De Weert, D | 1 |
| Feyaerts, M | 1 |
| Biegon, A | 1 |
| Essar, N | 1 |
| Israeli, M | 1 |
| Elizur, A | 1 |
| Bruch, S | 1 |
| Bar-Nathan, AA | 1 |
| James, D | 1 |
| Timmerman, L | 2 |
| de Beurs, P | 2 |
| Tan, BK | 2 |
| Leijnse-Ybema, H | 1 |
| Sanchez, C | 1 |
| Høpfner Petersen, HE | 1 |
| Cohen Stuart, MH | 1 |
| Theodorou, AE | 1 |
| Katona, CL | 1 |
| Davies, SL | 1 |
| Hale, AS | 1 |
| Kerry, SM | 1 |
| Horton, RW | 1 |
| Kelly, JS | 1 |
| Paykel, ES | 1 |
| Li, SW | 1 |
| Yan, HQ | 1 |
| Morgado, A | 1 |
| Raoux, N | 1 |
| Smith, M | 1 |
| Allilaire, JF | 1 |
| Widlöcher, D | 1 |
| Terashima, Y | 1 |
| Ichikawa, T | 1 |
| Koizumi, J | 1 |
| Molcan, J | 2 |
| Mrna, B | 1 |
| Krekule, P | 1 |
| Janecková, E | 1 |
| Koníková, M | 1 |
| Obrovská, V | 1 |
| Misurec, J | 1 |
| Libigerová, E | 1 |
| Kennedy, SH | 1 |
| Craven, JL | 1 |
| Rodin, GM | 1 |
| Roin, GM | 1 |
| Poelinger, W | 1 |
| Haber, H | 1 |
| Beckmann, H | 1 |
| Becker, T | 1 |
| Ghadirian, AM | 1 |
| Ananth, J | 1 |
| Tollefson, GD | 1 |
| Montague-Clouse, J | 1 |
| Lesan, T | 1 |
| Garvey, MJ | 1 |
| Den Boer, JA | 1 |
| Westenberg, HG | 1 |
| Pecknold, JC | 1 |
| Familamiri, P | 1 |
| McClure, DJ | 1 |
| Elie, R | 1 |
| Chang, H | 1 |
| Steardo, L | 1 |
| Barone, P | 1 |
| Monteleone, P | 1 |
| Iovino, M | 1 |
| Cardone, G | 1 |
| Koenig, W | 1 |
| Pfaff, G | 1 |
| Brusov, OS | 1 |
| Beliaev, BS | 1 |
| Katasonov, AB | 1 |
| Zlobina, GP | 1 |
| Factor, MI | 1 |
| Lideman, RR | 1 |
| Ross, SB | 1 |
| Kelder, D | 1 |
| Hrdina, PD | 2 |
| Lapierre, YD | 2 |
| Matousek, M | 1 |
| Isbir, T | 1 |
| Unal, M | 1 |
| Yesilsoy, C | 1 |
| Tukel, S | 1 |
| Ostrow, D | 1 |
| Montejo-Iglesias, ML | 1 |
| Ramos-Brieva, JA | 1 |
| Eberhard, G | 1 |
| von Knorring, L | 1 |
| Nilsson, HL | 1 |
| Sundequist, U | 1 |
| Björling, G | 1 |
| Linder, H | 1 |
| Svärd, KO | 1 |
| Tysk, L | 1 |
| Møller, SE | 1 |
| Leijnse-Ybema, HJ | 1 |
| Stuart, MH | 1 |
| Petersen, HE | 1 |
| Emrich, HM | 1 |
| Riemann, D | 1 |
| Baumgartner, A | 1 |
| Gräf, KJ | 1 |
| Kürten, I | 1 |
| van de Putte, JJ | 3 |
| Kamp, JS | 3 |
| Blansjaar, BA | 2 |
| Kramer, HJ | 2 |
| Haffmans, J | 2 |
| Horn, E | 1 |
| Bakish, D | 1 |
| Browne, M | 1 |
| Scatton, B | 2 |
| Dennis, T | 2 |
| Garreau, M | 1 |
| Oakley, AM | 1 |
| Hodge, L | 1 |
| Drebit, R | 1 |
| Baker, GB | 1 |
| Dewhurst, WG | 1 |
| Stieglitz, RD | 1 |
| Fonck, ML | 1 |
| Vergara, F | 1 |
| Metzger, R | 1 |
| Bouchard, JM | 1 |
| Delaunay, J | 1 |
| Delisle, JP | 1 |
| Grasset, N | 1 |
| Mermberg, PF | 1 |
| Molczadzki, M | 1 |
| Pagot, R | 1 |
| Richou, H | 1 |
| Robert, G | 1 |
| Ropert, R | 1 |
| Baumann, P | 3 |
| Bosshart, P | 1 |
| Gabris, G | 1 |
| Koeb, L | 1 |
| Woggon, B | 1 |
| Weinstein, RP | 1 |
| Gosselin, JY | 1 |
| Kurata, K | 2 |
| Kido, H | 2 |
| Hasegawa, M | 2 |
| Inoue, M | 2 |
| Yamaguchi, N | 2 |
| Léouffre, P | 1 |
| Gay, C | 1 |
| Kolomazník, M | 1 |
| Korínková, V | 1 |
| Zizka, V | 1 |
| Gaertner, H | 1 |
| Rein, W | 2 |
| Axmann, D | 1 |
| Peselow, ED | 1 |
| Lautin, A | 1 |
| Wolkin, A | 1 |
| Rohrs, C | 1 |
| Novatt, A | 1 |
| Siekierski, J | 1 |
| Rotrosen, J | 1 |
| Kissling, W | 2 |
| Herberger, B | 1 |
| Spahn, H | 1 |
| Siegfried, K | 1 |
| O'Connolly, M | 1 |
| Ngo Khac, T | 1 |
| Gilsdorf, U | 1 |
| Gelzer, J | 1 |
| Richter, MA | 1 |
| Joffe, RT | 1 |
| Gnirss, FA | 1 |
| Heimann, H | 2 |
| Simon, JS | 1 |
| Bottermann, P | 1 |
| Lehmann, HJ | 1 |
| Buchholz, G | 1 |
| Bernard, PG | 1 |
| Levine, MS | 1 |
| Buckler, RA | 1 |
| Friedman, JH | 1 |
| Zák, F | 1 |
| Szebeni, R | 1 |
| Udelman, DL | 1 |
| Udelman, HD | 1 |
| Lindsay, PG | 1 |
| Olsen, RB | 1 |
| Schmauss, M | 1 |
| Dieterle, D | 1 |
| Blaschke, D | 1 |
| Palha, AP | 1 |
| Ferreira, L | 1 |
| Abreu-Lima, C | 1 |
| Ramalhão, C | 1 |
| Fernandes, R | 1 |
| Fabre, LF | 1 |
| Prien, RF | 1 |
| Blaine, JD | 1 |
| Levine, J | 1 |
| Dessain, EC | 1 |
| Woods, BT | 1 |
| Sandyk, R | 1 |
| DeCastro, RM | 1 |
| Olie, JP | 1 |
| Susini de Luca, H | 1 |
| Kameyama, T | 1 |
| Nagasaka, M | 1 |
| Yamada, K | 1 |
| Ovuga, E | 1 |
| György, S | 1 |
| Révai, K | 1 |
| Demeter, E | 1 |
| Kranzler, H | 1 |
9 reviews available for maprotiline and Depression, Endogenous
| Article | Year |
|---|---|
[Biochemical aspects of using antidepressants in late middle age and the elderly (review)].
Topics: Age Factors; Aged; Aging; Antidepressive Agents; Catechol O-Methyltransferase; Depression; Depressiv | 1983 |
[Current treatment of depression].
Topics: Administration, Oral; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Depression; Depress | 1983 |
Maprotiline.
Topics: Animals; Anthracenes; Chemical Phenomena; Chemistry; Depressive Disorder; Drug Interactions; Electro | 1982 |
Acute therapy of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Drug Admin | 1993 |
Time course of improvement under antidepressant treatment: a survival-analytical approach.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Diso | 1993 |
Review of the cardiovascular effects of heterocyclic antidepressants.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Bupropion; | 1993 |
Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzamides; Clinical Trials as | 1995 |
Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice.
Topics: Amoxapine; Animals; Antidepressive Agents; Comorbidity; Contraindications; Depressive Disorder; Dose | 1999 |
Limits to chemotherapy of depression.
Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Maprotiline; S | 1986 |
108 trials available for maprotiline and Depression, Endogenous
| Article | Year |
|---|---|
[Comparative observation on efficacy of jieyu pill and maprotiline in treating depression].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive | 2004 |
[Clinical observation on effect of danzhi xiaoyao powder in treating depression].
Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drugs, Chinese Herbal; Femal | 2006 |
Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients.
Topics: Aged; Angina Pectoris; Anthracenes; Blood Pressure; Cardiac Complexes, Premature; Clinical Trials as | 1984 |
Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; | 1983 |
Evaluating the effectiveness of the new antidepressants.
Topics: Amoxapine; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Maprotiline | 1983 |
Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability.
Topics: Adolescent; Adult; Age Factors; Aged; Anthracenes; Cardiovascular System; Clinical Trials as Topic; | 1983 |
[Management of therapy-resistant depression with Ludiomil].
Topics: Anthracenes; Clinical Trials as Topic; Depressive Disorder; Humans; Maprotiline | 1983 |
Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Topics: Anthracenes; Clinical Trials as Topic; Constipation; Depressive Disorder; Dizziness; Double-Blind Me | 1983 |
Multicenter evaluation of maprotiline hydrochloride for treatment of depression.
Topics: Adolescent; Adult; Aged; Anthracenes; Anxiety; Clinical Trials as Topic; Constipation; Depressive Di | 1984 |
Speed of onset of action of the newer antidepressants.
Topics: Amitriptyline; Amoxapine; Antidepressive Agents; Clinical Trials as Topic; Depression; Depressive Di | 1984 |
[Anxiolytic effect of the beta1-receptor blocker metoprolol. Comparative study with oxazepam in patients receiving concomitant basic antidepressive therapy].
Topics: Anthracenes; Anxiety; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Hu | 1984 |
Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
Topics: Adult; Aged; Anthracenes; Antidepressive Agents; Brompheniramine; Depression; Depressive Disorder; E | 1981 |
Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
Topics: Animals; Anthracenes; Brompheniramine; Clinical Trials as Topic; Depressive Disorder; Double-Blind M | 1981 |
Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1982 |
[The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
Topics: Affect; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Bl | 1982 |
Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline.
Topics: Anthracenes; Depressive Disorder; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylgl | 1981 |
[Comparison of the therapeutic effects of lofepramine and maprotiline in depression].
Topics: Anthracenes; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Humans; Lofepramine; Map | 1982 |
Recognition and treatment of depression in a family medicine practice.
Topics: Adult; Aged; Ambulatory Care; Depressive Disorder; Family Practice; Female; Follow-Up Studies; Human | 1983 |
Mianserin, maprotiline and intracardiac conduction.
Topics: Adolescent; Adult; Anthracenes; Arrhythmias, Cardiac; Depressive Disorder; Dibenzazepines; Double-Bl | 1983 |
Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline".
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; | 1980 |
Maprotiline versus imipramine and placebo in neurotic depression.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1981 |
Factors which affect antidepressant drug responses in a multicenter controlled trial [proceedings].
Topics: Adult; Age Factors; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Humans; Imipramine; | 1981 |
Neurotropic drugs as co-medication to psychotropics. Combined administration of a neurotropic drug and a tetracyclic antidepressant.
Topics: Adolescent; Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Drug Synergism; Drug | 1980 |
Maprotiline (Ludiomil)--another antidepressant.
Topics: Anthracenes; Clinical Trials as Topic; Depressive Disorder; Humans; Maprotiline | 1981 |
Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
Topics: Adult; Amitriptyline; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Metho | 1980 |
[Depressive states, occurrence and treatment in family practice. Randomized study of the efficacy of maprotiline (Ludiomil) and flupenthixol (Fluanxol)].
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Denmark; Depressive Disorder; Double-Blind Metho | 1981 |
[Comparative clinical study of the association of chlordiazepoxide-amitriptyline and maprotiline in patients suffering from depression with anxiety components].
Topics: Adult; Aged; Amitriptyline; Anthracenes; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depres | 1981 |
[Further clinical experiences with maprotiline in endogeneous depressions].
Topics: Anthracenes; Clinical Trials as Topic; Depressive Disorder; Humans; Maprotiline; Middle Aged; Psychi | 1982 |
Worldwide clinical experience with ludiomil.
Topics: Anthracenes; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double | 1982 |
[Maprotiline and its undesired effects].
Topics: Anthracenes; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Female; Hemodynamics; Hu | 1982 |
Clinical experience with maprotiline.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Mapro | 1982 |
Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Family Practice; Female | 1994 |
Multicenter double-blind study of moclobemide and maprotiline.
Topics: Adult; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; | 1994 |
Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy.
Topics: Adult; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Drug Adm | 1994 |
Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female | 1994 |
Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
Topics: Adolescent; Adult; Aged; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; | 1993 |
Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Hospitalization; Humans; Male; Maprotilin | 1993 |
Not significantly different is not the same as significantly similar.
Topics: Amitriptyline; Antidepressive Agents; Data Interpretation, Statistical; Depressive Disorder; Humans; | 1993 |
Dynamics of the effects of levoprotiline and maprotiline on EEG in patients with major depressive episodes (DSM-III-R).
Topics: Adult; Antidepressive Agents; Depressive Disorder; Electroencephalography; Female; Humans; Male; Map | 1993 |
Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Electroencephalography; Female; Growth Horm | 1993 |
Time course of improvement under antidepressant treatment: a survival-analytical approach.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Diso | 1993 |
Video rating analysis of effect of maprotiline in patients with dementia and depression.
Topics: Aged; Aged, 80 and over; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; M | 1993 |
Noradrenergic and serotoninergic depression?
Topics: Adult; Aged; Brain; Clomipramine; Depressive Disorder; Dexamethasone; Humans; Hydrocortisone; Maprot | 1993 |
A clinical test of noradrenergic involvement in the therapeutic mode of action of an experimental antidepressant.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Female; Huma | 1993 |
Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
Topics: Adult; Analysis of Variance; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; | 1993 |
A double-blind, multicentre study of paroxetine and maprotiline in major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Dru | 1996 |
Cardiovascular effects of fluvoxamine and maprotiline in depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Depressive Disorder; Double-B | 1995 |
Recovery from depression: triggers and time patterns.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Drug Administration Schedule; Humans; Map | 1996 |
Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Depressive Disorder; Female; Fluox | 1997 |
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Dr | 1997 |
A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind | 1997 |
Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Drug Interactions; Drug Resista | 1997 |
Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline | 1997 |
Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Maprotil | 1999 |
Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopr | 2000 |
Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile.
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Depressive Disorder; Double-Blind Method; Female; | 2001 |
[Results of a clinical trial of levoprotiline].
Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprot | 1992 |
Thyroid hormones, body temperature, and antidepressant treatment.
Topics: Adult; Aged; Body Temperature; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans | 1992 |
[Comparative study of age-related effectiveness of tri- and tetracyclic antidepressants].
Topics: Affective Disorders, Psychotic; Age Factors; Aged; Amitriptyline; Bipolar Disorder; Depressive Disor | 1991 |
[Psychopathologic and psychophysiologic follow-up of inpatient depressed patients with standardized treatment with clomipramine and oxaprotiline].
Topics: Adult; Antidepressive Agents; Arousal; Clomipramine; Depressive Disorder; Dose-Response Relationship | 1991 |
[A randomized controlled trail of maprotiline treatment of depressive disorder].
Topics: Depressive Disorder; Female; Humans; Male; Maprotiline | 1991 |
Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Blood Platelets; Depressive Disorder; Double-Blin | 1991 |
A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression.
Topics: Adult; Ambulatory Care; Depressive Disorder; Female; Humans; Male; Maprotiline; Mianserin; Middle Ag | 1991 |
Therapeutic sleep deprivation and antidepressant medication in patients with major depression.
Topics: Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Fluvoxam | 1991 |
A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression.
Topics: Adolescent; Adult; Aged; Body Weight; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; | 1991 |
Prophylactic efficacy of maprotiline on unipolar depression relapse.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; | 1991 |
[Treatment of drug-resistant depression by intravenous administration of antidepressants].
Topics: Administration, Oral; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dibe | 1990 |
Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.
Topics: Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged | 1990 |
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients.
Topics: Adult; Aged; Bipolar Disorder; Citalopram; Depressive Disorder; Female; Humans; Male; Maprotiline; M | 1990 |
Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
Topics: Adult; Aged; Anthracenes; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Heart Rate; | 1990 |
A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
Topics: Aged; Aged, 80 and over; Anthracenes; Depressive Disorder; Double-Blind Method; Drug Administration | 1990 |
Moclobemide compared with second-generation antidepressants in elderly people.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method | 1990 |
A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Topics: Adult; Aged; Anthracenes; Blood Platelets; Citalopram; Clinical Trials as Topic; Depressive Disorder | 1987 |
Major depression in renal dialysis patients: an open trial of antidepressant therapy.
Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Desipramine; Humans; Kid | 1989 |
Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female | 1989 |
Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
Topics: Anthracenes; Benzamides; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1989 |
Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.
Topics: Adult; Agoraphobia; Anthracenes; Anxiety Disorders; Brain; Clinical Trials as Topic; Depressive Diso | 1988 |
Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
Topics: Adult; Ambulatory Care; Anthracenes; Anti-Anxiety Agents; Blood Pressure; Body Weight; Cardiovascula | 1985 |
Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixene.
Topics: Adult; Aged; Anthracenes; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Benzodiazepines; Benzo | 1988 |
Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects.
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Huma | 1985 |
Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects.
Topics: Animals; Anthracenes; Depressive Disorder; Female; Humans; Hypothalamus; Male; Maprotiline; Norepine | 1986 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; | 1985 |
Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study.
Topics: Adult; Animals; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fem | 1987 |
Therapeutic effect of maprotiline and chlorimipramine: controlled study.
Topics: Adult; Anthracenes; Bipolar Disorder; Clinical Trials as Topic; Clomipramine; Depressive Disorder; F | 1988 |
A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind | 1988 |
CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
Topics: Anthracenes; Antidepressive Agents; Blood Pressure; Clinical Trials as Topic; Clomipramine; Depressi | 1988 |
Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
Topics: Adult; Aged; Amino Acids; Anthracenes; Antidepressive Agents; Citalopram; Depressive Disorder; Femal | 1986 |
Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
Topics: Adult; Aged; Anthracenes; Antidepressive Agents; Depressive Disorder; Dexamethasone; Female; Fluvoxa | 1987 |
Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
Topics: Adult; Anthracenes; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; | 1988 |
Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relat | 1988 |
Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Doxepin; Female; Humans; Male; Maprotiline; Middl | 1988 |
Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind | 1987 |
Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients.
Topics: Adult; Aged; Anthracenes; Citalopram; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1987 |
Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
Topics: Adult; Aged; Anthracenes; Citalopram; Depressive Disorder; Dexamethasone; Female; Humans; Male; Mapr | 1987 |
[Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Huma | 1986 |
Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.
Topics: Amitriptyline; Anthracenes; Antidepressive Agents; Arousal; Clinical Trials as Topic; Depressive Dis | 1986 |
The dexamethasone suppression test and response to placebo.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; | 1986 |
Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy | 1986 |
Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
Topics: Aged; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Cognition; Depressive Disorder; | 1986 |
Comparison of oral and intravenous treatment of depressive states: preliminary results of a WHO collaborative study.
Topics: Administration, Oral; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Huma | 1986 |
Biological predictors of success of antidepressant drug therapy.
Topics: Age Factors; Anthracenes; Circadian Rhythm; Clomipramine; Depressive Disorder; Drug Administration S | 1987 |
The dexamethasone suppression test and antidepressant response in major depression.
Topics: Adolescent; Adult; Aged; Anthracenes; Depressive Disorder; Dexamethasone; Dose-Response Relationship | 1987 |
[Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline].
Topics: Adult; Amitriptyline; Anthracenes; Antidepressive Agents; Contingent Negative Variation; Depressive | 1987 |
Maprotiline in pain-depression.
Topics: Adult; Aged; Anthracenes; Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; D | 1985 |
Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
Topics: Adult; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Electroenc | 1985 |
A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; | 1985 |
Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Topics: Adult; Ambulatory Care; Amoxapine; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Diben | 1985 |
L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carbidopa; Clinical Trials as Topic; Depressive Disorder; Drug Res | 1985 |
134 other studies available for maprotiline and Depression, Endogenous
| Article | Year |
|---|---|
Complex visual disturbances during maprotiline treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Hallucinations; Humans; Maprot | 2012 |
Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain; Clomipramine; Depressive Disorder; Dose-Response Relat | 2002 |
Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
Topics: Cyclohexanols; Depressive Disorder; Emergency Medical Services; Humans; Male; Maprotiline; Middle Ag | 2004 |
Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity.
Topics: Adiponectin; Adult; Antidepressive Agents, Second-Generation; Body Mass Index; Body Weight; Depressi | 2008 |
[Management of treatment-resistant depression without ECT (author's transl)].
Topics: Antipsychotic Agents; Clomipramine; Depressive Disorder; Female; Humans; Male; Maprotiline; Nomifens | 1981 |
[Treatment of endogenous depressions with maprotiline, clomipramine, dibenzepine and pyrlindole (author's transl)].
Topics: Adult; Antidepressive Agents; Carbazoles; Clomipramine; Depressive Disorder; Dibenzazepines; Female; | 1981 |
[Treatment of therapy-refractory depressions].
Topics: Anthracenes; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Depressive Disorder; Drug Th | 1982 |
Depression in the elderly: pharmacologic considerations in treatment.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; De | 1982 |
Dexamethasone suppression test as a predictor of drug treatment response.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Dexamethasone; Dibenzazepines; | 1984 |
Maprotiline in the treatment of endogenous depression: comparison of therapeutic effect with serotonin level in blood platelets.
Topics: Adult; Aged; Animals; Anthracenes; Blood Platelets; Depressive Disorder; Female; Humans; Hydroxyindo | 1983 |
Maprotiline in affective illness. Plasma concentration and clinical response.
Topics: Adolescent; Adult; Aged; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle | 1983 |
Seizures associated with high maprotiline serum concentrations.
Topics: Adult; Anthracenes; Depressive Disorder; Dose-Response Relationship, Drug; Epilepsy, Tonic-Clonic; F | 1983 |
Maprotiline poisoning: a case of cardiotoxicity and myoclonic seizures.
Topics: Aged; Anthracenes; Depressive Disorder; Epilepsies, Myoclonic; Heart Block; Humans; Hypotension; Mal | 1984 |
[A preventive study using maprotiline in patients with periodic endogenous depression].
Topics: Adult; Aged; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged | 1984 |
Maprotiline hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram.
Topics: Anthracenes; Catatonia; Depressive Disorder; Diazepam; Drug Therapy, Combination; Electroencephalogr | 1984 |
[When do I give which antidepressant in the individual case?].
Topics: Anthracenes; Antidepressive Agents; Clomipramine; Depressive Disorder; Humans; Maprotiline; Monoamin | 1984 |
Simultaneous measurement of various antidepressants in the plasma of depressed patients by high performance liquid chromatography.
Topics: Adult; Amitriptyline; Amoxapine; Antidepressive Agents; Chromatography, High Pressure Liquid; Clomip | 1984 |
Facial EMG activity levels predict treatment outcome in depression.
Topics: Amitriptyline; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Desipramine; Electromyo | 1984 |
[Value of maprotiline (Ludiomil) as a 2% drinkable suspension in current psychiatric practice].
Topics: Adjustment Disorders; Administration, Oral; Adult; Aged; Anthracenes; Depressive Disorder; Depressiv | 1983 |
[Use of maprotiline in primary and secondary anxio-depressive syndromes in the aged].
Topics: Aged; Anthracenes; Anxiety Disorders; Depressive Disorder; Drug Evaluation; Female; Humans; Male; Ma | 1983 |
Effect of sleep deprivation as a predictor of treatment response to antidepressant medication.
Topics: Adult; Aged; Anthracenes; Clomipramine; Depressive Disorder; Female; Humans; Male; Maprotiline; Midd | 1983 |
Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
Topics: Adult; Aged; Anthracenes; Catechol O-Methyltransferase; Clomipramine; Depressive Disorder; Dopamine | 1983 |
Galactorrhea associated with maprotiline HCl.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Galactorrhea; Humans; Lactation Disorders; Maprotil | 1983 |
Effect of propranolol on maprotiline clearance.
Topics: Adult; Anthracenes; Depressive Disorder; Drug Interactions; Humans; Hydroxylation; Liver Circulation | 1984 |
Atrial flutter and maprotiline: case report.
Topics: Aged; Anthracenes; Atrial Flutter; Depressive Disorder; Female; Humans; Maprotiline | 1984 |
[A profile of the clinical effectiveness of second generation antidepressive agents].
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Isoquinolines; Male; Maprotiline; Middle Ag | 1984 |
Electrocardiographic changes during treatment with maprotiline and mianserin.
Topics: Adult; Anthracenes; Depressive Disorder; Dibenzazepines; Electrocardiography; Female; Heart Rate; Hu | 1984 |
Hepatotoxicity associated with maprotiline therapy: case report.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anthracenes; Aspartate Aminotransferases; Chemica | 1984 |
[Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses].
Topics: Amitriptyline; Antidepressive Agents; Arousal; Depressive Disorder; Double-Blind Method; Electroence | 1984 |
Mianserin versus maprotiline in patients with a depressive syndrome.
Topics: Adult; Aged; Anthracenes; Chemical Phenomena; Chemistry; Depressive Disorder; Dibenzazepines; Drug E | 1984 |
Maprotiline hydrochloride and convulsions: a case report.
Topics: Aminophylline; Anthracenes; Depressive Disorder; Drug Interactions; Epilepsy, Tonic-Clonic; Heart Fa | 1982 |
Maprotiline and seizures.
Topics: Adult; Anthracenes; Chlorpromazine; Depressive Disorder; Drug Therapy, Combination; Epilepsy, Tonic- | 1982 |
Grand mal seizures induced by maprotiline.
Topics: Adult; Anthracenes; Depressive Disorder; Dose-Response Relationship, Drug; Epilepsy, Tonic-Clonic; H | 1982 |
Seizures associated with maprotiline.
Topics: Anthracenes; Depressive Disorder; Epilepsy, Tonic-Clonic; Female; Humans; Maprotiline; Middle Aged | 1982 |
Concurrent use of antidepressants and propranolol: case report and theoretical considerations.
Topics: Anthracenes; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Maprotiline; Middle Aged; | 1983 |
Maprotiline-induced hypnopompic hallucinations.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Hallucinations; Humans; Male; Maprotiline; Sleep St | 1983 |
Seizures associated with maprotiline.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Seizures | 1983 |
Monoamine oxidase activity in platelets before and after sleep deprivation as predictor for antidepressive drug response.
Topics: Antidepressive Agents; Blood Platelets; Clomipramine; Depressive Disorder; Female; Humans; Kinetics; | 1983 |
Maprotiline-induced myoclonus.
Topics: Anthracenes; Depressive Disorder; Female; Humans; Maprotiline; Middle Aged; Myoclonus | 1983 |
Some thoughts on a new antidepressant and a marking of the death of John Cade, MD.
Topics: Anthracenes; Australia; Depressive Disorder; History, 20th Century; Humans; Lithium; Maprotiline | 1981 |
Maprotiline versus imipramine.
Topics: Anthracenes; Depressive Disorder; Humans; Imipramine; Maprotiline | 1982 |
Use of antidepressants in childhood: results of maprotiline (Ludiomil) treatment in 20 cases.
Topics: Adolescent; Anthracenes; Child; Child, Preschool; Depressive Disorder; Female; Humans; Male; Maproti | 1982 |
[Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
Topics: Administration, Oral; Adult; Aged; Anthracenes; Depressive Disorder; Female; Humans; Infusions, Pare | 1982 |
[Analysis of the efficacy of EEG after maprotiline administration].
Topics: Adult; Alpha Rhythm; Anthracenes; Beta Rhythm; Cerebral Cortex; Depressive Disorder; Dominance, Cere | 1982 |
[Maprotiline in psychiatric ambulatory care].
Topics: Adult; Ambulatory Care; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Psychia | 1982 |
[The antidepressive maprotiline: symposium at Hradec Kralove 26 November 1980].
Topics: Anthracenes; Antidepressive Agents; Depressive Disorder; Humans; Maprotiline | 1982 |
To the pharmacological profile of maprotiline.
Topics: Abnormalities, Drug-Induced; Adult; Animals; Anthracenes; Arousal; Chick Embryo; Depressive Disorder | 1982 |
[Ambulatory treatment of masked depressions with maprotiline].
Topics: Adult; Ambulatory Care; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Psychop | 1982 |
Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
Topics: Administration, Oral; Adult; Anthracenes; Clomipramine; Depressive Disorder; Drug Therapy, Combinati | 1982 |
[Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
Topics: Adult; Anthracenes; Bipolar Disorder; Clomipramine; Depressive Disorder; Drug Therapy, Combination; | 1982 |
[The effect of maprotiline on target symptoms of depressive states].
Topics: Adolescent; Adult; Aged; Anthracenes; Depressive Disorder; Female; Humans; Imipramine; Male; Maproti | 1982 |
[Ambulatory treatment of larvate depressions with maprotiline ].
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged | 1982 |
Seizures and maprotiline.
Topics: Anthracenes; Depressive Disorder; Humans; Male; Maprotiline; Middle Aged; Seizures | 1982 |
Recently introduced antidepressants: their place in clinical practice.
Topics: Amoxapine; Antidepressive Agents; Bundle of His; Chemical Phenomena; Chemistry; Depressive Disorder; | 1982 |
Liquid-chromatographic determination of amitryptyline and its metabolites in serum, with adsorption onto glass minimized.
Topics: Adsorption; Amitriptyline; Binding, Competitive; Chromatography, High Pressure Liquid; Depressive Di | 1982 |
[Treatment of therapy-resistant depressions. Results of combined infusion treatment].
Topics: Anthracenes; Clomipramine; Depressive Disorder; Female; Humans; Infusions, Parenteral; Male; Maproti | 1982 |
Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
Topics: Adult; Amitriptyline; Anthracenes; Body Weight; Depressive Disorder; Dibenzazepines; Drug Evaluation | 1982 |
Recognizing and treating depressed patients with maprotiline.
Topics: Adolescent; Adult; Aged; Anthracenes; Depressive Disorder; Humans; Maprotiline; Middle Aged | 1982 |
Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
Topics: Adult; Aged; Anthracenes; Depressive Disorder; Female; Glycols; Humans; Male; Maprotiline; Methoxyhy | 1982 |
[Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
Topics: Adult; Anthracenes; Clomipramine; Depressive Disorder; Desipramine; Female; Growth Hormone; Humans; | 1980 |
[Paradoxical akinesia induced by antidepressant drugs (author's transl)].
Topics: Aged; Antidepressive Agents, Tricyclic; Catalepsy; Cataplexy; Depressive Disorder; Dyskinesia, Drug- | 1980 |
Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings].
Topics: Depressive Disorder; Glycols; Humans; Hydrocortisone; Imipramine; Maprotiline; Methoxyhydroxyphenylg | 1981 |
Do have antidepressants of the second generation anxiolytic properties?
Topics: Adult; Anthracenes; Anxiety; Depressive Disorder; Humans; Isoquinolines; Maprotiline; Middle Aged; M | 1981 |
Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.
Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents, Tricyclic; Blood Platelets; Clomipramine; | 1980 |
MHPG as a predictor of antidepressant response to imipramine and maprotiline.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Glycols; Humans; Imipramine; Male; Maprotiline; Met | 1980 |
[Psychotropic drug-induced myoclonus].
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Clozapine; Depressive D | 1995 |
Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Electroencephalogr | 1994 |
[Follow-up of Werlhof disease after onset of treatment with maprotiline].
Topics: Amitriptyline; Cilazapril; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Comb | 1995 |
[A case of rare side effects of certain antidepressive drugs].
Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Diagnosis, Differential; Drug Thera | 1995 |
Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
Topics: Bronchial Spasm; Bronchitis; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Ephedr | 1995 |
Is there any specific personality disorder or personality disorder cluster that worsens the short-term treatment outcome of major depression?
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Depressive Disorder; Dose- | 1993 |
Pharmacotherapy of delusional depression: experience with combinations of antidepressants with the neuroleptics zotepine and haloperidol.
Topics: Adult; Amitriptyline; Antipsychotic Agents; Delusions; Depressive Disorder; Dibenzothiepins; Dose-Re | 1994 |
[Infusion therapy with antidepressants in patients with depression].
Topics: Adult; Aged; Aged, 80 and over; Clomipramine; Depressive Disorder; Female; Follow-Up Studies; Humans | 1993 |
The Pisa syndrome (pleurothotonus) during antidepressant therapy.
Topics: Amitriptyline; Antidepressive Agents; Biperiden; Depressive Disorder; Dose-Response Relationship, Dr | 1997 |
[A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, T | 1997 |
Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?
Topics: Alleles; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Depressive Disorder; Genotype; H | 1997 |
Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chemical and Drug Induce | 1998 |
Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; C-Peptide; Depressive Disorder; Diab | 1999 |
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cathartics; Cholinergic Antagonists; | 2000 |
Low frequency rTMS as an add-on antidepressive strategy: heterogeneous impact on 99mTc-HMPAO and 18 F-FDG uptake as measured simultaneously with the double isotope SPECT technique. Pilot study.
Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Citalopram; Depressive Disorder; Female; Fluorod | 2001 |
Quadricyclic antidepressant overdosage in a patient with AIDS under mega-highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antidepressive Agents, Second-Generation; Antiretroviral | 2001 |
Increased plasma concentration of maprotiline by coadministration of risperidone.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fema | 2002 |
Possible contributory role of the central histaminergic system in the forced swimming model.
Topics: Animals; Antidepressive Agents; Brain Chemistry; Central Nervous System; Depressive Disorder; Diseas | 1992 |
Falling spells associated with antidepressant drug treatment.
Topics: Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Dyskinesia, Drug-Induced; Humans; M | 1992 |
Alpha 2-adrenoceptor responsivity in depression: effect of chronic treatment with moclobemide, a selective MAO-A-inhibitor, versus maprotiline.
Topics: Adult; Benzamides; Clonidine; Depressive Disorder; Female; Growth Hormone; Humans; Insulin-Like Grow | 1990 |
Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients.
Topics: Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Maprotiline; Monoamine Oxidase Inhi | 1991 |
Predictive value of two endogenicity measures.
Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Female; Hostility; Humans; Ma | 1990 |
Serotonin 5-HT2 receptor binding on blood platelets as a state dependent marker in major affective disorder.
Topics: Adult; Aged; Biomarkers; Blood Platelets; Cell Membrane; Depressive Disorder; Female; Humans; Ketans | 1990 |
Pharmacological specificity is not the same as clinical selectivity.
Topics: Depressive Disorder; Double-Blind Method; Humans; Hydroxyindoleacetic Acid; Maprotiline; Methoxyhydr | 1987 |
3H-imipramine binding to freshly prepared platelet membranes in depression.
Topics: Adult; Aged; Bipolar Disorder; Blood Platelets; Carrier Proteins; Depressive Disorder; Dexamethasone | 1989 |
[Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Topics: Adult; Anthracenes; Antidepressive Agents; Arousal; Benzamides; Depressive Disorder; Female; Humans; | 1989 |
Maprotiline (Ludiomil) treatment of mental depression--a clinical report of 65 cases.
Topics: Adolescent; Adult; Aged; Anthracenes; Constipation; Depressive Disorder; Female; Humans; Male; Mapro | 1989 |
Subjective bias in reports of poor work adjustment in depressed patients.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Follow-Up Studies; Humans; Job Satisfaction; Male; | 1989 |
An adult case of psychogenic alopecia universalis.
Topics: Adult; Alopecia; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Job Satisfaction; Male; | 1989 |
Comparative study of levoprotiline and amitriptyline in endogenous depressions.
Topics: Adult; Aged; Amitriptyline; Anthracenes; Antidepressive Agents; Depressive Disorder; Female; Humans; | 1989 |
Position of levoprotiline in the treatment of acute endogenous depression.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged | 1989 |
Infusions of maprotiline in depressive out-patients.
Topics: Ambulatory Care; Anthracenes; Depressive Disorder; Female; Humans; Infusion Pumps; Male; Maprotiline | 1989 |
Safety of maprotiline in treatment of cardiac patients with left anterior hemiblock.
Topics: Anthracenes; Depressive Disorder; Electrocardiography; Female; Heart Block; Heart Rate; Humans; Male | 1989 |
Pharmacokinetic properties of maprotiline in geriatric depression.
Topics: Aged; Anthracenes; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Mapr | 1989 |
Long term treatment with oxaprotiline in patients with major depression.
Topics: Adult; Aged; Anthracenes; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Maprotil | 1989 |
Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression?
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Clomipramine; Depressive Disord | 1987 |
Does platelet serotonin receptor supersensitivity accompany endogenous depression?
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Blood Platelets; Carbazoles; Depressive Disorder; Fe | 1989 |
Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients.
Topics: Anthracenes; Chromatography, Gas; Depressive Disorder; Humans; Maprotiline; Psychiatric Status Ratin | 1986 |
EEG assessment of the sedative and excitatory properties of CNS-active compounds in the patients with depression.
Topics: Anthracenes; Arousal; Attention; Depressive Disorder; Electroencephalography; Evoked Potentials; Hum | 1987 |
Action of maprotiline on the erythrocyte membrane Na+-K+/Mg++ ATPase and Ca++/Mg++ ATPase in depressed patients.
Topics: Adenosine Triphosphatases; Anthracenes; Depressive Disorder; Erythrocyte Membrane; Humans; Maprotili | 1987 |
Prolactin in patients with major depressive disorder and in healthy subjects. II. Longitudinal study of basal prolactin and post-TRH-stimulated prolactin levels.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Longi | 1988 |
[Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol].
Topics: Adult; Antidepressive Agents; Brain; Depressive Disorder; Dexamethasone; Female; Glycols; Humans; Ma | 1985 |
Cutaneous vasculitis from maprotiline.
Topics: Aged; Anthracenes; Depressive Disorder; Drug Eruptions; Female; Humans; Maprotiline; Vasculitis, Leu | 1985 |
Determination of maprotiline and desmethylmaprotiline in plasma and urine by gas chromatography with nitrogen-phosphorus detection.
Topics: Adult; Anthracenes; Chromatography, Gas; Depressive Disorder; Female; Humans; Indicators and Reagent | 1988 |
EEG characteristics of clinically defined on-drug-responders and non-responders--a comparison clomipramine vs. maprotiline.
Topics: Adult; Aged; Anthracenes; Clomipramine; Depressive Disorder; Electroencephalography; Female; Humans; | 1988 |
[Depression in cerebrovascular disorders: a prospective study and the effect of maprotiline therapy].
Topics: Adult; Aged; Cerebrovascular Disorders; Depressive Disorder; Female; Humans; Male; Maprotiline; Midd | 1988 |
Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoin.
Topics: Acetylation; Anthracenes; Debrisoquin; Depressive Disorder; Gas Chromatography-Mass Spectrometry; Hu | 1988 |
Case report of hepatotoxicity associated with maprotiline.
Topics: Anthracenes; Chemical and Drug Induced Liver Injury; Depressive Disorder; Female; Humans; Liver Func | 1988 |
Serum levels of maprotiline and its adverse effects on depressed patients.
Topics: Adult; Anthracenes; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationshi | 1987 |
A comparison of maprotiline and its desmethylated metabolite serum concentrations in outpatients and inpatients.
Topics: Adult; Ambulatory Care; Anthracenes; Depressive Disorder; Dose-Response Relationship, Drug; Female; | 1987 |
Use of tricyclic antidepressants in a patient with malignant hyperthermia.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Female; Humans; Malignant | 1987 |
Depression and sleep disorders. The optical isomers of oxaprotiline and their effect on sleep parameters in healthy subjects.
Topics: Adult; Anthracenes; Depressive Disorder; Humans; Male; Maprotiline; Norepinephrine; Sleep; Sleep Wak | 1986 |
New aspects in research on blood levels and bioavailability of antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Biological Availability; Debrisoquin; Depressive Disorder; Hum | 1986 |
Psychophysiological aspects of depressive syndromes.
Topics: Adult; Amitriptyline; Arousal; Autonomic Nervous System; Depressive Disorder; Electroencephalography | 1987 |
The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Double-Blind Method; Endorphins; Female; Hu | 1986 |
[Atypical facial neuralgia or depressive facial pain. Diagnostic aspects of a well-demarcated form of masked depression].
Topics: Aged; Clomipramine; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Facial | 1986 |
Maprotiline-induced seizures.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Maprotiline; Seizures | 1986 |
Maprotiline-induced ataxia.
Topics: Anthracenes; Cerebellar Ataxia; Depressive Disorder; Humans; Male; Maprotiline; Middle Aged | 1986 |
A new compound of tetracyclic structure, maprotiline (Ludiomil) in the treatment of depression.
Topics: Anthracenes; Depressive Disorder; Female; Humans; Male; Maprotiline | 1985 |
A preliminary report on anti-depressant therapy and its effects on hope and immunity.
Topics: Adult; Anthracenes; B-Lymphocytes; Depressive Disorder; Emotions; Female; Humans; Immunity; Interleu | 1985 |
Antidepressant drug therapy: the role of the new antidepressants.
Topics: Amoxapine; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Depressive Disorder; Drug Eval | 1985 |
Maprotiline treatment in depression. A perspective on seizures.
Topics: Adult; Aged; Anthracenes; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Mal | 1986 |
Speech blockage induced by maprotiline.
Topics: Anthracenes; Depressive Disorder; Humans; Male; Maprotiline; Middle Aged; Speech Disorders | 1986 |
Antidepressants and myoclonus: case report.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Maprotiline; Middle Aged; Myoclonus; Ser | 1985 |
Hypothesis of a deficiency of central noradrenergic input in DST nonsuppressor depressed patients. A clinical study with determination of DST and plasma DOPEG: negative results.
Topics: Brain; Depressive Disorder; Dexamethasone; Glycols; Humans; Hypothalamo-Hypophyseal System; Maprotil | 1985 |
Effects of antidepressant drugs on a quickly-learned conditioned-suppression response in mice.
Topics: Acridines; Amitriptyline; Animals; Antidepressive Agents; Depressive Disorder; Desipramine; Diphenhy | 1985 |
Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
Topics: Adolescent; Adult; Anthracenes; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Humans | 1985 |
Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
Topics: Adult; Aged; Amitriptyline; Anthracenes; Bipolar Disorder; Depressive Disorder; Dexamethasone; Femal | 1985 |
Tonic-clonic seizures with maprotiline.
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Maprotiline; Seizures | 1985 |